QurieGen

1 known investors

QurieGen develops QuRIE-seq, a single-cell multi-omics platform that captures time-resolved single-cell data and trains lab-in-the-loop AI Virtual Cell models to predict cellular behavior and drug response. Spun out of the Huck Lab at Radboud University, the company serves pharmaceutical drug discovery and R&D.